Science Abstracts
Calcineurin inhibitors for the treatment of atopic dermatitis
March 2010
March 2010
Authors : Jan Ehrchen , Cord Sunderkötter , Thomas Luger , Martin Steinhoff
Affliation : University of Muenster, Boltzmann-Institute for Cell- and Immunobiology of the Skin, Department of Dermatology, 58, Von Esmarch Str, D-48149 Muenster, Germany ; ; Cord.Sunderkoetter@ukmuenster.de
DOI : 10.1517/14656560802498040
Published in : Expert Opin. Pharmacother.
Subject:
Keywords: atopic dermatitis (AD) , calcineurin inhibitor , inflammatory skin disease , pimecrolimus , T cells , tacrolimus
Abstract
Please Login to read the full article.
RELATED CONTENT
NEWS
- US FDA advisory committees back randomised trials for LABA safety
- GAO: FDA is lax in enforcing Phase IV studies for surrogate endpoint drugs
- Revised US HIV treatment guidelines call for a return to "hit hard, hit early"
- Novartis reports positive data for second fingolimod Phase III study in MS - update
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
